When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine

Detalles Bibliográficos
Autores principales: Dal-Ré, Rafael, Banzi, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973077/
https://www.ncbi.nlm.nih.gov/pubmed/33810939
http://dx.doi.org/10.1016/j.ejim.2021.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973077/
https://www.ncbi.nlm.nih.gov/pubmed/33810939
http://dx.doi.org/10.1016/j.ejim.2021.03.016

Ejemplares similares